Cargando…

Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease

BACKGROUND: Huntington disease (HD) is caused by a polyglutamine expansion of more than 35 units in the huntingtin protein. This expanded repeat length inversely correlates with the age-at-onset (AAO), however, additional genetic factors apart from the expanded CAG repeat size are thought to influen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Che, Hong Van B, Metzger, Silke, Portal, Esteban, Deyle, Carolin, Riess, Olaf, Nguyen, Huu Phuc
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022537/ https://www.ncbi.nlm.nih.gov/pubmed/21211002 http://dx.doi.org/10.1186/1750-1326-6-1

Ejemplares similares

The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients
por: Metzger, Silke, et al.
Publicado: (2013)

Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients
por: Tsai, Yu-Chun, et al.
Publicado: (2012)

Reduced Motivation in the BACHD Rat Model of Huntington Disease Is Dependent on the Choice of Food Deprivation Strategy
por: Jansson, Erik Karl Håkan, et al.
Publicado: (2014)

The BACHD Rat Model of Huntington Disease Shows Signs of Fronto-Striatal Dysfunction in Two Operant Conditioning Tests of Short-Term Memory
por: Clemensson, Erik Karl Håkan, et al.
Publicado: (2017)

The gene coding for PGC-1α modifies age at onset in Huntington's Disease
por: Weydt, Patrick, et al.
Publicado: (2009)

Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease
por: Clemensson, Erik Karl Håkan, et al.
Publicado: (2017)

PGC-1alpha as modifier of onset age in Huntington disease
por: Taherzadeh-Fard, Elahe, et al.
Publicado: (2009)

The Guanine Nucleotide Exchange Factor Kalirin-7 Is a Novel Synphilin-1 Interacting Protein and Modifies Synphilin-1 Aggregate Transport and Formation
por: Tsai, Yu-Chun, et al.
Publicado: (2012)

Correction: Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease
por: Clemensson, Erik Karl Håkan, et al.
Publicado: (2019)

The calpain-suppressing effects of olesoxime in Huntington's disease
por: Weber, Jonasz J., et al.
Publicado: (2016)

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2012)

Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease
por: El Massioui, Nicole, et al.
Publicado: (2016)

Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington’s disease
por: Jesse, Sarah, et al.
Publicado: (2017)

The Alteration of Emotion Regulation Precedes the Deficits in Interval Timing in the BACHD Rat Model for Huntington Disease
por: Garces, Daniel, et al.
Publicado: (2018)

Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington disease
por: Singer, Elisabeth, et al.
Publicado: (2017)

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease
por: Taherzadeh-Fard, Elahe, et al.
Publicado: (2011)

Reduction in Subventricular Zone-Derived Olfactory Bulb Neurogenesis in a Rat Model of Huntington’s Disease Is Accompanied by Striatal Invasion of Neuroblasts
por: Kandasamy, Mahesh, et al.
Publicado: (2015)

Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals
por: Yu-Taeger, Libo, et al.
Publicado: (2022)

Reversal Learning and Associative Memory Impairments in a BACHD Rat Model for Huntington Disease
por: Abada, Yah-se K., et al.
Publicado: (2013)

Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease
por: Faure, Alexis, et al.
Publicado: (2013)

Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease
por: Yu-Taeger, Libo, et al.
Publicado: (2019)

Mitochondrial Dysfunction in Huntington’s Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors
por: Intihar, Taylor A., et al.
Publicado: (2019)

Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice
por: Nguyen, Huu Phuc, et al.
Publicado: (2013)

A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort
por: Weydt, Patrick, et al.
Publicado: (2014)

Assessment of Motor Function, Sensory Motor Gating and Recognition Memory in a Novel BACHD Transgenic Rat Model for Huntington Disease
por: Abada, Yah-se K., et al.
Publicado: (2013)

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease
por: Nguyen, Huu Phuc, et al.
Publicado: (2010)

The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease
por: Singer, Elisabeth, et al.
Publicado: (2021)

Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1α deacetylation
por: Lee, Mijung, et al.
Publicado: (2018)

Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease
por: Novati, Arianna, et al.
Publicado: (2018)

Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats
por: Antonsen, Bjørnar T., et al.
Publicado: (2012)

Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the Mouse
por: Piccinin, Elena, et al.
Publicado: (2019)

PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response
por: Abu Shelbayeh, Othman, et al.
Publicado: (2023)

Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
por: Saft, Carsten, et al.
Publicado: (2023)

A map of the PGC-1α- and NT-PGC-1α-regulated transcriptional network in brown adipose tissue
por: Chang, Ji Suk, et al.
Publicado: (2018)

NMDA receptor gene variations as modifiers in Huntington disease: a replication study
por: Saft, Carsten, et al.
Publicado: (2011)

PGC1α: Friend or Foe in Cancer?
por: Mastropasqua, Francesca, et al.
Publicado: (2018)

Transcriptional Activity of PGC-1α and NT-PGC-1α Is Differentially Regulated by Twist-1 in Brown Fat Metabolism
por: Jun, Hee-Jin, et al.
Publicado: (2012)

Early Deficits in Glycolysis Are Specific to Striatal Neurons from a Rat Model of Huntington Disease
por: Gouarné, Caroline, et al.
Publicado: (2013)

SUMO-modifying Huntington’s disease
por: Soares, Ericks S., et al.
Publicado: (2022)

The BACHD Rat Model of Huntington Disease Shows Specific Deficits in a Test Battery of Motor Function
por: Manfré, Giuseppe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ck9ve3f3peo1o22qnuff529l8f